DOCEREE
Doceree healthcare HCP-targeted programmatic advertising platform.
Définition
Doceree platform : (1) ESPYIAN (Doceree proprietary AI identification engine, identifies + verifies HCPs across digital channels via EHRs + NPI verification + multi-attribute matching). (2) Ad Inventory : ~5000+ HCPs digital touchpoints (EHR systems + medical apps + medical websites + pharma reps' iPad detail-aid + medical literature platforms). (3) Demand-Side Platform (DSP) : pharma companies launch programmatic campaigns target specific HCPs profiles by specialty + geography + behavior. (4) Supply-Side Platform (SSP) : medical publishers + EHR vendors + medical apps monetize HCP inventory via Doceree exchange. (5) Compliance HIPAA + Sunshine Act compliance + PHARMA Code (no patient PHI ever processed, only verified-HCP identity), no targeting individual patients (forbidden by HIPAA + ethics). (6) Use cases : pharma launches new drug awareness campaign target oncologists USA who prescribed competitor drug, programmatic ad served in EHR sidebar while oncologist reviews patient charts. Doceree employees ~150 (Princeton NJ headquarters + Bangalore India tech center + ~6 country offices including UK + Brazil + India + UAE + Singapore + Japan).
Origine
Doceree Inc. fondee 2020 Princeton NJ par Harshit Jain MD ; Series A $11M juin 2021 (Eight Roads Ventures) ; Series B $35M mai 2024 (Mensch Capital lead) ; total funding ~$50M+.
Exemple en contexte
Big Pharma X launches new diabetes drug awareness campaign targeting US endocrinologists : Doceree platform identifies ~14000 US endocrinologists via NPI matching, programmatic ads served in Epic EHR sidebar + Doximity app + Medscape articles when endocrinologists active, conversion measured by Doceree click-through + script-lift via downstream pharmacy claims data analysis.
Termes liés
- Carequality — healthcare interoperability framework.